Global Nuclear Medicine Diagnostics Market is expected to reach $18.2 Oct.2016 | Page 2

Global Nuclear Medicine Diagnostics Market According to the report "Nuclear Medicine Diagnostics Market ", published by Market Data Forecast, the global market is projected to reach USD 18.27 Billion by 2020, at a CAGR of 13.2% from 2015 to 2020. For full report refer to http://www.marketdataforecast.com/market-reports/globalnuclear-medicine-diagnostics-market-123/ Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, accurate diagnosis of the patient's illness. The emerging market will be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-nuclear-medicine-diagnostics-market-123/request-sample Increasing practice of SPECT and PET in medical diagnostics in various geographies, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are the major driving factors of the market. However, short half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are the major restrains for the nuclear medicine market growth. Global market for Nuclear medicine diagnostics is segmented into two major segments By type (SPECT, PET) and application By Type 1.SPECT     Technetium-99m (TC-99m) Iodine (I-123) Thallium-201 (TL-201) and Others 2.PET    Rubidium-82 (RB-82), Fluorine-18 and Others By Application 1.SPECT      lymphoma, cardiology, neurology, thyroid oncology, [phone] | www.marketdataforecast.com | [email protected]